Azumamides A-E: Isolation, Synthesis, Biological Activity, and Structure-Activity Relationship.

Area of Science:

• Medicinal Chemistry
• Natural Products Chemistry
• Biochemistry

Background:

• Cyclic peptides are a significant class of histone deacetylase (HDAC) inhibitors.
• Following romidepsin's clinical success, research intensified on naturally occurring cyclic peptides with hydrophilic moieties as potential HDAC inhibitors.
• Azumamides A-E, isolated from *Mycale izuensis*, represent a potent class of HDAC inhibitors.

Purpose of the Study:

• To review synthetic methodologies for azumamides A-E, focusing on beta-amino acid synthesis and macrocyclization.
• To overview the structure-activity relationships (SAR) of azumamides A-E and their analogs.
• To highlight the therapeutic potential of azumamides A-E as HDAC inhibitors and guide future research on cyclic peptide HDAC inhibitors.

Main Methods:

• Detailed review of published synthetic routes for azumamides A-E.
• Focus on strategies for synthesizing unnatural beta-amino acids (Amnna, Amnda).
• Analysis of macrocyclization techniques employed in azumamide synthesis.

Main Results:

• Azumamides A-E possess a unique retro-arrangement peptide backbone due to D-amino acid configurations.
• The synthesis involves complex beta-amino acid construction and macrocyclization steps.
• SAR studies indicate specific structural features contribute to HDAC inhibitory activity.

Conclusions:

• Azumamides A-E demonstrate significant potential as HDAC inhibitors.
• Understanding their synthetic pathways and SAR is crucial for drug development.
• This review provides insights into the broader class of cyclic peptide HDAC inhibitors.